-
Product Insights
Tenda – Origin Santo Andre Residencial Complex – Sao Paulo
The Tenda – Origin Santo Andre Residencial Complex – Sao Paulo project involves the construction of a residential complex on 5504.71m2 of land in Santo André, São Paulo, Brazil. Equip yourself with the essential tools needed to make informed and profitable decisions with our Tenda – Origin Santo Andre Residencial Complex – Sao Paulo report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...
-
Product Insights
Origin Wind Energy Project
Origin Wind Energy Project is an Onshore Wind project located in Oklahoma, United States. The project is owned by Gulf Plains Wind LLC and was developed by Origin Wind Energy LLC. The project came online in 2014. Empower your strategies with our Origin Wind Energy Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Company Insights
Innovation and Patenting activity of Origin Enterprises PLC Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Origin Enterprises PLC Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Origin Energy Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Origin Energy Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval Analysis for Malignant Fibrous Histiocytoma of Soft Tissue
Overview How likely is it that the drugs in Malignant Fibrous Histiocytoma of Soft Tissue will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Fibrous Histiocytoma of Soft Tissue Overview Malignant...
-
Sector Analysis
NewEgypt Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Egypt Defense Market - Size and trends, budget allocation, regulations, key acquisitions, competitive landscape and forecast, 2024-2029 report provides the market size forecast and the projected growth rate for the next five years. The report covers industry analysis including the key market drivers, emerging technology trends, and major challenges faced by market participants. It also offers insights regarding key factors and government programs that are expected to influence the demand for military platforms over the forecast period. Egyptian defense and...
-
Product Insights
NewLikelihood of Approval Analysis for Choroidal Neovascularization
Overview How likely is it that the drugs in Choroidal Neovascularization will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Choroidal Neovascularization Overview Choroidal neovascularization (CNV) involves the growth of new blood...
-
Product Insights
NewLikelihood of Approval Analysis for Leiomyosarcoma
Overview How likely is it that the drugs in Leiomyosarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leiomyosarcoma Overview Leiomyosarcoma is an aggressive soft tissue sarcoma derived from smooth muscle...
-
Company Insights
NewFiserv – Competitor Profile
Fiserv is a leading global provider of payments and financial services. It provides a wide range of services, including electronic payment processing for electronic bill payments; account-to-account transfers; debit and credit card processing and services; internet and mobile banking systems; card and print personalization services; loan origination and servicing products; as well as fraud and risk management services. Launched in 1984, the company offers its services to over 10,000 financial institution clients in over 100 countries. The company mostly offers...
-
Product Insights
NewLikelihood of Approval Analysis for Salivary Gland Cancer
Overview How likely is it that the drugs in Salivary Gland Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salivary Gland Cancer Overview Salivary gland cancer refers to malignant tumors...